Revises requirements for administration of vaccines to patients.
Summary
Senate Bill 1305 would change the informed-consent process for administering vaccines in New Jersey. It requires a health care practitioner to provide, at least 48 hours before vaccination, the vaccine insert, a CDC-prepared excipient summary, and information about the Vaccine Adverse Event Reporting System (VAERS), including reporting instructions and federal vaccine injury tables. For unemancipated minors, these materials must be given to a parent or guardian.
The bill also requires the patient, or the patient’s parent or guardian, to be given an explicit option to opt out of vaccination, along with an explanation of the possible consequences of declining, including disease transmission risks and possible school attendance limits absent a medical or religious exemption. A vaccine may be administered only after a signed copy of the vaccine insert is returned confirming consent. The bill further bars a practitioner from refusing to provide care or transferring a patient solely because the patient declines vaccination.
Impact
The bill would add new pre-vaccination disclosure and consent requirements to Title 26 of the Revised Statutes and would regulate how health care practitioners obtain consent before administering any vaccine. It would create a 48-hour advance notice obligation, require distribution of specific federal vaccine-related materials, and condition administration on a signed acknowledgment form. It would also limit provider responses to vaccine refusal by prohibiting denial of care or transfer of care solely on that basis. The practical effect would be to impose additional administrative steps on clinicians and to expand the documentation patients receive before vaccination.
Sentiment
No committee transcripts or recorded votes were provided, so there is no direct evidence of legislative debate or formal support/opposition in the available record. Based on the bill text, the sponsors appear to be advancing a patient-choice and disclosure-focused approach to vaccination. The measure’s structure suggests an emphasis on informed consent, vaccine risk information, and preserving access to care for patients who decline vaccination.
Contention
The main points of contention are likely to center on whether the bill improves informed consent or instead creates barriers to timely vaccination. Supporters would likely emphasize disclosure, parental awareness, and the right to decline vaccination without losing access to care. Opponents would likely argue that the 48-hour waiting period, required paperwork, and opt-out counseling could discourage vaccination, complicate clinical workflows, and conflict with existing immunization practices and school-entry requirements. The requirement to provide VAERS and vaccine-injury materials may also be controversial if viewed as overstating risks or implying a level of caution not required under current law.